Commercialization of many biotechnology inventions is dependent on securing adequate patent protection. Biotechnology inventions can be hard to patent because of the large amount of supporting data ordinarily required to support broad patent claims. Accumulating data takes time, which is in tension with the need to file patent applications at an early stage of development. Making the determination of when there is sufficient data available to file a patent application presents a significant challenge.
At this free lunch-hour session, attendees will:
- Learn the current legal test for evaluating sufficiency of disclosure in Canada;
- Learn generally how the position in Canada is different from that in other key jurisdictions, including the United States and Europe; and
- Be guided through a detailed analysis of two cases that illustrate how the patent office examines the issue of sufficiency of disclosure, to gain a better understanding of the type of data that is required to support a successful patent application.
Who Should Attend?
This seminar will be at an intermediate level, and is directed to entrepreneurs and scientists who are involved with IP, but who are not lawyers or patent agents. It will be of interest to those who are involved in developing IP strategy, evaluating inventions for potential patentability, or who are involved in the patent application process. It will also be of interest to those with some familiarity with patents who are looking to expand their knowledge of the specific requirements for obtaining patent protection for an invention.
Registration will open at 11:30 a.m., a light lunch will be served from 12:00 to 12:30 p.m., and the seminar will take place between 12:30 and 1:30 p.m. There will be time for questions both during and after the seminar.
There is parking available on site, and the hotel is located a short walk from the Broadway-City Hall stop on the Canada Line or the 99 B-Line stops at Willow Street (westbound) or Heather Street (eastbound).